drugset / Trial / NCT01547559
Research for Prevention and Treatment of NSAIDs Related Gastrointestinal Side Effects
RandomizedParallel-groupSingle-blindPrevention
Summary
We aim to evaluate the protective effects of eradication of HP and continue using Geranylgeranylacetone (GGA) on NSAIDs related gastroenterological lesions. We further aim to explore the effect of GGA on small-intestinal mucosal injuries induced by diclofenac sodium in patients with rheumatic diseases who didn't take NSAIDs in the preceding 6 months.
Timeline
- Start
- 2007-06
- Primary completion
- 2014-11
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amoxicillin | Other / unclassified | 1 g | — |
| Subject | Clarithromycin | Small molecule | 500 mg | — |
| Subject | Esomeprazole | Small molecule | 20 mg | — |
| Subject | Metronidazole | Small molecule | 500 mg | — |
| Subject | Teprenone | Unknown | 50 mg | — |
| Background | Diclofenac | Other / unclassified | 75 mg | — |